Cell-penetrating peptide (CPP) has been found to have strong cellular translocation properties and drug delivery potential. Currently, a variety of cell delivery studies have focused on the covalent conjugates of CPPs with various types of PNAs. For example, CPP conjugation can increase the solubility of PNAs and reduce its physiological clearance by promoting cellular internalization.
The global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates include HLB panagene, LifeTein, Smartox Biotechnology (SB-PEPTIDE), PANAGENE, Creative Biogene, Creative Peptides, SBS Genetech, Medtide Inc, PNA BIO INC, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates.
The CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
HLB panagene
LifeTein
Smartox Biotechnology (SB-PEPTIDE)
PANAGENE
Creative Biogene
Creative Peptides
SBS Genetech
Medtide Inc
PNA BIO INC
by Type
(KFF)4K Based
(RXR)5XB Based
Other
by Application
Molecular Probes
Gene Editing
Drug Development
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Overview
1.1 Product Definition
1.2 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates by Type
1.2.1 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Value Comparison by Type (2024-2030)
1.2.2 (KFF)4K Based
1.2.3 (RXR)5XB Based
1.2.4 Other
1.3 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates by Application
1.3.1 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Value by Application (2024-2030)
1.3.2 Molecular Probes
1.3.3 Gene Editing
1.3.4 Drug Development
1.3.5 Other
1.4 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Size Estimates and Forecasts
1.4.1 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue 2019-2030
1.4.2 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales 2019-2030
1.4.3 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Competition by Manufacturers
2.1 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales Market Share by Manufacturers (2019-2024)
2.2 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue Market Share by Manufacturers (2019-2024)
2.3 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates, Product Type & Application
2.7 Global Key Manufacturers of CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates, Date of Enter into This Industry
2.8 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Competitive Situation and Trends
2.8.1 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Concentration Rate
2.8.2 The Global 5 and 10 Largest CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Players Market Share by Revenue
2.8.3 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Scenario by Region
3.1 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales by Region: 2019-2030
3.2.1 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales by Region: 2019-2024
3.2.2 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales by Region: 2025-2030
3.3 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue by Region: 2019-2030
3.3.1 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue by Region: 2019-2024
3.3.2 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue by Region: 2025-2030
3.4 North America CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Facts & Figures by Country
3.4.1 North America CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales by Country (2019-2030)
3.4.3 North America CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Facts & Figures by Country
3.5.1 Europe CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales by Country (2019-2030)
3.5.3 Europe CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Facts & Figures by Region
3.6.1 Asia Pacific CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales by Region (2019-2030)
3.6.3 Asia Pacific CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Facts & Figures by Country
3.7.1 Latin America CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales by Country (2019-2030)
3.7.3 Latin America CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Facts & Figures by Country
3.8.1 Middle East and Africa CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales by Country (2019-2030)
3.8.3 Middle East and Africa CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales by Type (2019-2030)
4.1.1 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales by Type (2019-2024)
4.1.2 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales by Type (2025-2030)
4.1.3 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales Market Share by Type (2019-2030)
4.2 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue by Type (2019-2030)
4.2.1 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue by Type (2019-2024)
4.2.2 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue by Type (2025-2030)
4.2.3 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue Market Share by Type (2019-2030)
4.3 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Price by Type (2019-2030)
5 Segment by Application
5.1 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales by Application (2019-2030)
5.1.1 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales by Application (2019-2024)
5.1.2 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales by Application (2025-2030)
5.1.3 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales Market Share by Application (2019-2030)
5.2 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue by Application (2019-2030)
5.2.1 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue by Application (2019-2024)
5.2.2 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue by Application (2025-2030)
5.2.3 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Revenue Market Share by Application (2019-2030)
5.3 Global CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Price by Application (2019-2030)
6 Key Companies Profiled
6.1 HLB panagene
6.1.1 HLB panagene Company Information
6.1.2 HLB panagene Description and Business Overview
6.1.3 HLB panagene CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.1.4 HLB panagene CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Product Portfolio
6.1.5 HLB panagene Recent Developments/Updates
6.2 LifeTein
6.2.1 LifeTein Company Information
6.2.2 LifeTein Description and Business Overview
6.2.3 LifeTein CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.2.4 LifeTein CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Product Portfolio
6.2.5 LifeTein Recent Developments/Updates
6.3 Smartox Biotechnology (SB-PEPTIDE)
6.3.1 Smartox Biotechnology (SB-PEPTIDE) Company Information
6.3.2 Smartox Biotechnology (SB-PEPTIDE) Description and Business Overview
6.3.3 Smartox Biotechnology (SB-PEPTIDE) CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Smartox Biotechnology (SB-PEPTIDE) CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Product Portfolio
6.3.5 Smartox Biotechnology (SB-PEPTIDE) Recent Developments/Updates
6.4 PANAGENE
6.4.1 PANAGENE Company Information
6.4.2 PANAGENE Description and Business Overview
6.4.3 PANAGENE CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.4.4 PANAGENE CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Product Portfolio
6.4.5 PANAGENE Recent Developments/Updates
6.5 Creative Biogene
6.5.1 Creative Biogene Company Information
6.5.2 Creative Biogene Description and Business Overview
6.5.3 Creative Biogene CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Creative Biogene CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Product Portfolio
6.5.5 Creative Biogene Recent Developments/Updates
6.6 Creative Peptides
6.6.1 Creative Peptides Company Information
6.6.2 Creative Peptides Description and Business Overview
6.6.3 Creative Peptides CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Creative Peptides CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Product Portfolio
6.6.5 Creative Peptides Recent Developments/Updates
6.7 SBS Genetech
6.7.1 SBS Genetech Company Information
6.7.2 SBS Genetech Description and Business Overview
6.7.3 SBS Genetech CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.7.4 SBS Genetech CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Product Portfolio
6.7.5 SBS Genetech Recent Developments/Updates
6.8 Medtide Inc
6.8.1 Medtide Inc Company Information
6.8.2 Medtide Inc Description and Business Overview
6.8.3 Medtide Inc CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Medtide Inc CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Product Portfolio
6.8.5 Medtide Inc Recent Developments/Updates
6.9 PNA BIO INC
6.9.1 PNA BIO INC Company Information
6.9.2 PNA BIO INC Description and Business Overview
6.9.3 PNA BIO INC CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.9.4 PNA BIO INC CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Product Portfolio
6.9.5 PNA BIO INC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Industry Chain Analysis
7.2 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Production Mode & Process
7.4 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales and Marketing
7.4.1 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Sales Channels
7.4.2 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Distributors
7.5 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Customers
8 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Dynamics
8.1 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Industry Trends
8.2 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Drivers
8.3 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Challenges
8.4 CPP-PNA (Cell-penetrating Peptide-Peptide Nucleic Acid) Conjugates Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
HLB panagene
LifeTein
Smartox Biotechnology (SB-PEPTIDE)
PANAGENE
Creative Biogene
Creative Peptides
SBS Genetech
Medtide Inc
PNA BIO INC
听
听
*If Applicable.
